C5a-Inhibitor Deficiency — A Role in Familial Mediterranean Fever?
- 2 August 1984
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 311 (5) , 325-326
- https://doi.org/10.1056/nejm198408023110510
Abstract
The sequence of events that precipitate the recurrent febrile attacks of familial Mediterranean fever has fascinated clinicians ever since the disease became firmly established as a distinct clinical entity in 1945.1 Clues to its cause seemed to be provided by its prevalence in specific ethnic groups in the Mediterranean littoral, a high familial incidence, and the clinical manifestations of self-limited, febrile paroxysms and serosal inflammation. Early authors, impressed by the intermittency of attacks and a high incidence of atopy, searched vainly for an exogenous allergen. In a comprehensive study of the disease in Israel in 1958, Heller at al. postulated . . .Keywords
This publication has 6 references indexed in Scilit:
- C5a-Inhibitor Deficiency in Peritoneal Fluids from Patients with Familial Mediterranean FeverNew England Journal of Medicine, 1984
- Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean feverBlood, 1984
- A neutrophil lysozyme leak in patients with familial mediterranean feverAmerican Journal of Hematology, 1981
- Anaphylatoxins: C3a and C5aPublished by Elsevier ,1978
- FAMILIAL MEDITERRANEAN FEVER IN ARMENIANS. ANALYSIS OF 100 CASESMedicine, 1974
- Familial Mediterranean FeverArchives of internal medicine (1960), 1958